Skip to Main Content

Paper Details

Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
Nat Commun
59
2021
Author NameAffiliation
Bjoern MeyerCNRS, Institut Pasteur
Marius WalterBuck Institute for Research on Aging
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California san francisco
Eric VerdinBuck Institute for Research on Aging
Marco VignuzziCNRS, Institut Pasteur
  • 1 - 5

Datasets

Release 1.2